30. March 2011 13:41
The BioIndustry Association (BIA) and the Ethical Medicines Industry Group (EMIG) are to co-host a conference to explore the Government’s current health reforms.
‘The Future of UK Healthcare – how to achieve success in the new reality’ will analyse issues such as the impact the reforms will have on the UK life science industry and value-based pricing.
Leslie Galloway, Chairman of EMIG, says the conference will enable delegates to “develop a sharper focus on the outcomes of the major changes” taking place.
Confirmed speakers at the event include Lord Earl Howe, who will present the keynote address, Chris Brinsmead, Life Sciences Business Advisor, and Sir Andrew Dillon, NICE Chief Executive.
Nigel Gaymond, Chief Executive of the BIA (pictured), says the health reforms will have a “significant impact” for both bodies and the conference will “explore the key developments in the health environment”.
“This event is intended to foster new business development opportunities by bringing bioscience and pharma companies together for senior level networking,” he said.
“It further reflects the BIA’s commitment to work in partnership with other organisations to foster a spirit of greater collaboration across the life sciences sector.”
The conference will be held on Tuesday 24th May at the Royal Society, 6-9 Carlton House Terrace, London.